Ozempic, Wegovy, and GLP-1 in Canada: What's Covered and How to Get Access in 2026

GLP-1 medications are available in Canada, but provincial drug plan coverage is one of the most confusing aspects of the Canadian healthcare system to navigate. What's covered, what you pay out of pocket, and what your options are if your plan doesn't cover it all depends on your province, your diagnosis, and your insurance plan.

Here's how it actually works.

What Health Canada Has Approved

All are Health Canada approved. The access and coverage story varies significantly by province.

Provincial Drug Plan Coverage

Coverage for GLP-1s varies more by province than almost any other drug class in Canada. Here's the current picture:

Ontario (ODB):

• Ozempic for type 2 diabetes: covered for eligible patients
• Wegovy for obesity: limited/inconsistent coverage as of 2026. Ontario has been slower than other provinces to establish formal obesity coverage
• Private drug plans in Ontario vary by employer

British Columbia (PharmaCare):

• Ozempic for type 2 diabetes: covered under regular benefits
• Wegovy for obesity: coverage is restricted and requires special authority. Not routinely listed
• Fair PharmaCare applies income-based deductibles

Alberta (Alberta Blue Cross):

• Broader coverage than most provinces for both diabetes and obesity indications
• Wegovy can be covered under the Non-Group Benefits plan with prior authorization
• Alberta has been more progressive on obesity pharmacotherapy coverage

Manitoba, Saskatchewan: Diabetes indication generally covered; obesity indication limited.

Quebec (RAMQ):

• Ozempic for type 2 diabetes: listed
• Wegovy: not yet consistently covered for obesity

Private employer insurance: Most employer-sponsored drug plans cover GLP-1s for type 2 diabetes. Obesity coverage is plan-specific. Check your policy's formulary and whether prior authorization is required.

What You Pay Without Coverage

Manufacturer savings programs exist (Novo Nordisk and Eli Lilly both have Canadian patient assistance programs). Check the brand's website for eligibility.

Getting a Prescription

For diabetes: your GP, endocrinologist, or internist can prescribe.

For obesity (Wegovy/Zepbound): you'll typically need a documented BMI of 30 or higher, or 27 or higher with a comorbidity like hypertension or sleep apnea. Weight management clinics and endocrinologists are the most common prescribers for the obesity indication. Some GPs prescribe directly.

Telehealth options: Weight management telehealth services have expanded significantly in Canada post-pandemic. Several platforms offer GLP-1 prescriptions with follow-up care. Look for services operating in your province.

Compounded GLP-1 in Canada

Canada's compounding pharmacy framework operates differently from the US. Canadian compounding pharmacies are regulated provincially, and some have continued to offer compounded semaglutide and tirzepatide preparations even as US availability changed.

Availability of compounded GLP-1 varies significantly by province and pharmacy. Some provinces have clearer guidance than others. This route typically requires a prescription and a compounding pharmacy with relevant experience.

If cost is the primary barrier and brand-name coverage isn't available, this is worth discussing with a provider familiar with Canadian compounding pharmacy access.

Tracking Your GLP-1 Protocol

Whether you're on a brand-name pen or a compounded vial, tracking your GLP-1 dose and your health metrics together is what lets you know what's working.

The GLP-1 dose calculator calculates your exact injection volume for any compounded semaglutide or tirzepatide concentration. Free, no account required.

Ready to track your protocol?

• Smart reminders so you never miss a dose
• Progress tracking with photos and weight
• Medication level curves for every compound

Get Regimen Free

Frequently Asked Questions